David L. Laughton

684 total citations
13 papers, 570 citations indexed

About

David L. Laughton is a scholar working on Molecular Biology, Aging and Parasitology. According to data from OpenAlex, David L. Laughton has authored 13 papers receiving a total of 570 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Aging and 3 papers in Parasitology. Recurrent topics in David L. Laughton's work include Genetics, Aging, and Longevity in Model Organisms (5 papers), Parasites and Host Interactions (3 papers) and Parasite Biology and Host Interactions (2 papers). David L. Laughton is often cited by papers focused on Genetics, Aging, and Longevity in Model Organisms (5 papers), Parasites and Host Interactions (3 papers) and Parasite Biology and Host Interactions (2 papers). David L. Laughton collaborates with scholars based in United Kingdom, Sweden and Australia. David L. Laughton's co-authors include Adrian J. Wolstenholme, Andrew Walding, Sabina Alam, George G. Lunt, John Unitt, Garry Pairaudeau, Bob Thong, David W. Jenkins, Françoise Auchère and Håkan Eriksson and has published in prestigious journals such as Journal of Biological Chemistry, Nature Biotechnology and Cancer Research.

In The Last Decade

David L. Laughton

13 papers receiving 556 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David L. Laughton United Kingdom 11 197 157 132 108 71 13 570
Jon J. Vermeire United States 18 133 0.7× 305 1.9× 256 1.9× 127 1.2× 392 5.5× 26 885
Cecilia Fernández Uruguay 16 252 1.3× 23 0.1× 129 1.0× 56 0.5× 193 2.7× 22 573
Zhu Wang United States 13 241 1.2× 34 0.2× 136 1.0× 65 0.6× 203 2.9× 14 634
Alan R. Friedman United States 15 270 1.4× 24 0.2× 71 0.5× 42 0.4× 34 0.5× 28 621
Michael G. Thompson United Kingdom 17 445 2.3× 23 0.1× 74 0.6× 55 0.5× 32 0.5× 41 758
Yann Fédon France 14 329 1.7× 44 0.3× 23 0.2× 30 0.3× 12 0.2× 19 717
Sider Penkov Germany 13 224 1.1× 94 0.6× 60 0.5× 14 0.1× 16 0.2× 20 615
Patricia R. Komuniecki United States 17 240 1.2× 11 0.1× 136 1.0× 100 0.9× 99 1.4× 30 826
Míriam Paula Alonso Toldo Brazil 19 134 0.7× 77 0.5× 17 0.1× 34 0.3× 121 1.7× 43 701

Countries citing papers authored by David L. Laughton

Since Specialization
Citations

This map shows the geographic impact of David L. Laughton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Laughton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Laughton more than expected).

Fields of papers citing papers by David L. Laughton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. Laughton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Laughton. The network helps show where David L. Laughton may publish in the future.

Co-authorship network of co-authors of David L. Laughton

This figure shows the co-authorship network connecting the top 25 collaborators of David L. Laughton. A scholar is included among the top collaborators of David L. Laughton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Laughton. David L. Laughton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Leit, Silvana, David L. Laughton, Suzanne L. Jacques, et al.. (2022). Abstract 589: Discovery of NTX-001, a potent Cbl-b inhibitor with antitumor activity in syngeneic models. Cancer Research. 82(12_Supplement). 589–589. 1 indexed citations
2.
Forbes, Louisa V., Tove Sjögren, Françoise Auchère, et al.. (2013). Potent Reversible Inhibition of Myeloperoxidase by Aromatic Hydroxamates. Journal of Biological Chemistry. 288(51). 36636–36647. 88 indexed citations
3.
Luckhurst, Christopher A., M. Ratcliffe, Mark Furber, et al.. (2010). Synthesis and biological evaluation of N-alkylated 8-oxybenz[c]azepine derivatives as selective PPARδ agonists. Bioorganic & Medicinal Chemistry Letters. 21(1). 531–536. 10 indexed citations
4.
Sanganee, Hitesh J., Andrew Baxter, Alastair Brown, et al.. (2009). Discovery of small molecule human C5a receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 19(4). 1143–1147. 24 indexed citations
5.
Alam, Sabina, David L. Laughton, Andrew Walding, & Adrian J. Wolstenholme. (2005). Human peripheral blood mononuclear cells express GABAA receptor subunits. Molecular Immunology. 43(9). 1432–1442. 129 indexed citations
6.
Irvine, Alistair S., et al.. (2000). Efficient nonviral transfection of dendritic cells and their use for in vivo immunization. Nature Biotechnology. 18(12). 1273–1278. 77 indexed citations
7.
Laughton, David L., et al.. (1999). Ligand-gated chloride channel subunits encoded by the Haemonchus contortus and Ascaris suum orthologues of the Caenorhabditis elegans gbr-2 (avr-14) gene. Molecular and Biochemical Parasitology. 103(2). 129–140. 46 indexed citations
8.
9.
10.
Laughton, David L., George G. Lunt, & Adrian J. Wolstenholme. (1997). Reporter Gene Constructs Suggest That the Caenorhabditis Elegans Avermectin Receptor β-Subunit is Expressed Solely in the Pharynx. Journal of Experimental Biology. 200(10). 1509–1514. 55 indexed citations
11.
Laughton, David L., et al.. (1995). The β‐Subunit of Caenorhabditis elegans Avermectin Receptor Responds to Glycine and Is Encoded by Chromosome 1. Journal of Neurochemistry. 64(5). 2354–2357. 17 indexed citations
12.
Laughton, David L., Muriel Amar, Philippe Thomas, et al.. (1994). Cloning of a putative inhibitory amino acid receptor subunit from the parasitic nematode Haemonchus contortus.. PubMed. 2(2). 155–63. 36 indexed citations
13.
Jagadish, Mittur N., David L. Laughton, Ahmed A. Azad, & Ian Macreadie. (1991). Stable synthesis of viral protein 2 of infectious bursal disease virus in Saccharomyces cerevisiae. Gene. 108(2). 275–279. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jon J. Vermeire Breakdown of academic impact, for papers by Cecilia Fernández Breakdown of academic impact, for papers by Zhu Wang Breakdown of academic impact, for papers by Alan R. Friedman Breakdown of academic impact, for papers by Michael G. Thompson Breakdown of academic impact, for papers by Yann Fédon Breakdown of academic impact, for papers by Sider Penkov Breakdown of academic impact, for papers by Patricia R. Komuniecki Breakdown of academic impact, for papers by Míriam Paula Alonso Toldo
Rankless by CCL
2026